MX2020008458A - Composicion para la prevencion y el tratamiento de los trastornos del crecimiento del cabello. - Google Patents

Composicion para la prevencion y el tratamiento de los trastornos del crecimiento del cabello.

Info

Publication number
MX2020008458A
MX2020008458A MX2020008458A MX2020008458A MX2020008458A MX 2020008458 A MX2020008458 A MX 2020008458A MX 2020008458 A MX2020008458 A MX 2020008458A MX 2020008458 A MX2020008458 A MX 2020008458A MX 2020008458 A MX2020008458 A MX 2020008458A
Authority
MX
Mexico
Prior art keywords
hair growth
prevention
treatment
composition
growth disorders
Prior art date
Application number
MX2020008458A
Other languages
English (en)
Spanish (es)
Inventor
Giammaria Giuliani
Ralf Paus
Barbara Marzani
Sergio Baroni
Daniela Pinto
Nathan Hawkshaw
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Publication of MX2020008458A publication Critical patent/MX2020008458A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2020008458A 2018-02-13 2019-02-13 Composicion para la prevencion y el tratamiento de los trastornos del crecimiento del cabello. MX2020008458A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT201800002630A IT201800002630A1 (it) 2018-02-13 2018-02-13 Composizione per la prevenzione e il trattamento dei disturbi della crescita dei capelli
PCT/EP2019/053591 WO2019158607A1 (fr) 2018-02-13 2019-02-13 Composition pour la prévention et le traitement de troubles de la pousse des cheveux

Publications (1)

Publication Number Publication Date
MX2020008458A true MX2020008458A (es) 2022-07-19

Family

ID=62044904

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008458A MX2020008458A (es) 2018-02-13 2019-02-13 Composicion para la prevencion y el tratamiento de los trastornos del crecimiento del cabello.

Country Status (24)

Country Link
US (1) US11793792B2 (fr)
EP (1) EP3752253B1 (fr)
JP (1) JP7356984B2 (fr)
CN (1) CN111818973B (fr)
AU (1) AU2019221535A1 (fr)
CA (1) CA3090401A1 (fr)
DK (1) DK3752253T3 (fr)
EA (1) EA202091933A1 (fr)
ES (1) ES2954733T3 (fr)
FI (1) FI3752253T3 (fr)
HR (1) HRP20231043T1 (fr)
HU (1) HUE062748T2 (fr)
IL (1) IL276669A (fr)
IT (1) IT201800002630A1 (fr)
LT (1) LT3752253T (fr)
MA (1) MA51831B1 (fr)
MD (1) MD3752253T2 (fr)
MX (1) MX2020008458A (fr)
PL (1) PL3752253T3 (fr)
PT (1) PT3752253T (fr)
RS (1) RS64581B1 (fr)
SG (1) SG11202007410TA (fr)
SI (1) SI3752253T1 (fr)
WO (1) WO2019158607A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110882173B (zh) * 2019-12-05 2022-06-17 西北农林科技大学 一种靶向毛囊干细胞防治脱发的外用型日化品配方

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US7563813B2 (en) * 2005-05-13 2009-07-21 Wyeth Iminothiazolidinone derivatives as SFRP-1 antagonists
FR2891543A1 (fr) * 2005-10-05 2007-04-06 Oreal Composes phenyl-furyl-methyl-thiazolidine-2,4-diones ou phenyl-thienyl-methyl-thiazolidine-2,4-diones ; utilisations pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute ; compositions le contenant
US8859616B2 (en) * 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
FR3020951B1 (fr) 2014-05-16 2016-06-17 Pierre Fabre Dermo-Cosmetique Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique.

Also Published As

Publication number Publication date
IL276669A (en) 2020-09-30
MA51831A (fr) 2020-12-23
EP3752253B1 (fr) 2023-06-14
MA51831B1 (fr) 2023-09-27
DK3752253T3 (da) 2023-09-04
WO2019158607A1 (fr) 2019-08-22
CA3090401A1 (fr) 2019-08-22
EA202091933A1 (ru) 2020-12-29
LT3752253T (lt) 2023-10-10
JP7356984B2 (ja) 2023-10-05
ES2954733T3 (es) 2023-11-24
HRP20231043T1 (hr) 2023-12-22
US11793792B2 (en) 2023-10-24
JP2021513509A (ja) 2021-05-27
MD3752253T2 (ro) 2023-11-30
SI3752253T1 (sl) 2023-11-30
US20210000801A1 (en) 2021-01-07
HUE062748T2 (hu) 2023-12-28
FI3752253T3 (fi) 2023-09-01
PT3752253T (pt) 2023-09-04
PL3752253T3 (pl) 2023-12-04
BR112020016211A2 (pt) 2020-12-08
RS64581B1 (sr) 2023-10-31
EP3752253A1 (fr) 2020-12-23
CN111818973B (zh) 2023-08-22
CN111818973A (zh) 2020-10-23
AU2019221535A1 (en) 2020-10-01
IT201800002630A1 (it) 2019-08-13
SG11202007410TA (en) 2020-09-29

Similar Documents

Publication Publication Date Title
PH12018502634A1 (en) Topical compositions of apremilast
MX2023005636A (es) Inhibidores de bcl6 derivados de bencimidazolona.
WO2018143552A3 (fr) Composition injectable destinée à prévenir la perte de cheveux ou stimuler la pousse des cheveux
WO2019043450A3 (fr) Compositions cosmétiques ayant des propriétés antioxydantes
CR20220160A (es) Derivados de piridazin-3(2h)-ona fusionados con azol
MX2020010568A (es) Derivados de urea ciclica fusionada como antagonista de crhr2.
PH12019502850A1 (en) AMIDE DERIVATIVES AS Nav1.7 AND Nav1.8 BLOCKERS
EP4171606A4 (fr) Compositions et méthodes de traitement de la covid-19
CL2018000430A1 (es) Compuesto de hidroxitriazina y uso médico relacionado.
MX2021007425A (es) Derivados heterociclicos como bloqueadores de nav1.7 y nav1.8.
MX2020008458A (es) Composicion para la prevencion y el tratamiento de los trastornos del crecimiento del cabello.
EA202090122A1 (ru) Композиции на основе дутастерида для местного применения
MX2019010218A (es) Derivados de pirazol como inhibidores de bromodominio.
MX2021011986A (es) Metodos de tratamiento de dolor neuropatico.
MX2018000538A (es) Composicion antimicrobiana.
MX2020008300A (es) Uso de [6]-paradol para estabilizacion de composiciones cosmeticas.
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
MX2021014220A (es) Composiciones para el tratamiento de la perdida del cabello.
MX2020008082A (es) Compuestos y composiciones para el tratamiento del dolor.
GB2595502B (en) Compounds, compositions and methods for the treatment or prevention of hair loss
GB202016159D0 (en) Compound, compositions and methods for the treatment of pain
MX2022000781A (es) Triterpenoides sintéticos heteroaromáticos sustituidos polarmente en c17, y métodos de uso de los mismos.
EP4093870A4 (fr) Compositions pour le traitement de la shna et des troubles associés et méthodes d'utilisation desdites compositions
GB2574944B (en) Methods and compositions for the treatment of pain and/or inflammation
MX2022003164A (es) Composiciones para usar para la inhibicion de cinasa src y el tratamiento y la prevencion de trastornos asociados.